Vials that have been repeatedly frozen and thawed may contain mostly inactive peptide fragments
Multi-path support can match the complexity of the problem
In published research protocols, BPC-157 has been studied across a dosing range of 1-10 mcg/kg in animal models, with the majority of positive results observed at doses between 2-10 mcg/kg administered intraperitoneally or subcutaneously
Most visits take only a few minutes after the initial consult
100 Units = 1 ml 1 Unit = 0.01 ml Dose Calculation Examples Using a Reconstitution Calculator While the math is simple, the risk of error is high
What this means for you right now: BPC-157 and TB-500 are currently available through licensed compounding pharmacies under clinician supervision Thymosin Alpha-1 has a longer regulatory history and a more established compounding track record Sourcing from unregulated vendors carries real safety risks contamination, misdosing, and no quality control We've covered the full regulatory picture in detail here: PCAC Peptide Review 2026: What the July Advisory Panel Decision Means for BPC-157, TB-500, and Thymosin Alpha-1 What a Clinician-Supervised Long COVID Peptide Protocol Looks Like A responsible protocol starts with assessment not assumption